Kempner Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-77,210
| Closed | -$713K | – | 50 |
|
|
2019
Q2 | $713K | Hold |
77,210
| – | – | 0.47% | 40 |
|
|
2019
Q1 | $1.21M | Sell |
77,210
-21
| -0% | -$329 | 0.8% | 37 |
|
|
2018
Q4 | $1.19M | Sell |
77,231
-157
| -0.2% | -$2.42K | 0.82% | 35 |
|
|
2018
Q3 | $1.67M | Sell |
77,388
-41
| -0.1% | -$883 | 1.07% | 31 |
|
|
2018
Q2 | $1.88M | Sell |
77,429
-27
| -0% | -$657 | 1.24% | 31 |
|
|
2018
Q1 | $1.32M | Buy |
77,456
+272
| +0.4% | +$4.65K | 0.9% | 32 |
|
|
2017
Q4 | $1.46M | Sell |
77,184
-131,773
| -63% | -$2.5M | 0.91% | 32 |
|
|
2017
Q3 | $3.68M | Buy |
208,957
+5,275
| +3% | +$92.8K | 2.42% | 17 |
|
|
2017
Q2 | $6.77M | Buy |
203,682
+3,632
| +2% | +$121K | 4.45% | 6 |
|
|
2017
Q1 | $6.42M | Buy |
200,050
+31,860
| +19% | +$1.02M | 4.28% | 7 |
|
|
2016
Q4 | $6.1M | Buy |
168,190
+89,245
| +113% | +$3.24M | 4.43% | 4 |
|
|
2016
Q3 | $3.63M | Sell |
78,945
-2,800
| -3% | -$129K | 2.5% | 18 |
|
|
2016
Q2 | $4.11M | Hold |
81,745
| – | – | 2.64% | 18 |
|
|
2016
Q1 | $4.37M | Buy |
81,745
+27,155
| +50% | +$1.45M | 2.63% | 17 |
|
|
2015
Q4 | $3.58M | Buy |
54,590
+13,125
| +32% | +$861K | 2.1% | 22 |
|
|
2015
Q3 | $2.34M | Sell |
41,465
-27,680
| -40% | -$1.56M | 1.33% | 35 |
|
|
2015
Q2 | $4.09M | Buy |
69,145
+11,200
| +19% | +$662K | 2.13% | 20 |
|
|
2015
Q1 | $3.61M | Sell |
57,945
-46,510
| -45% | -$2.9M | 2.29% | 16 |
|
|
2014
Q4 | $6.01M | Sell |
104,455
-34,880
| -25% | -$2.01M | 2.7% | 12 |
|
|
2014
Q3 | $7.49M | Sell |
139,335
-6,600
| -5% | -$355K | 3.19% | 9 |
|
|
2014
Q2 | $7.65M | Sell |
145,935
-36,430
| -20% | -$1.91M | 3.03% | 12 |
|
|
2014
Q1 | $9.64M | Sell |
182,365
-46,840
| -20% | -$2.47M | 3.91% | 6 |
|
|
2013
Q4 | $9.19M | Sell |
229,205
-12,500
| -5% | -$501K | 3.9% | 7 |
|
|
2013
Q3 | $9.13M | Hold |
241,705
| – | – | 3.71% | 8 |
|
|
2013
Q2 | $9.48M | Buy |
+241,705
| New | +$9.48M | 3.97% | 6 |
|